ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SER Serina Therapeutics Inc

11.01
1.36 (14.09%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Serina Therapeutics Inc AMEX:SER AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  1.36 14.09% 11.01 11.35 9.81 9.96 16,053 01:00:00

Placing / Directors Holding

20/10/2003 5:41pm

UK Regulatory


RNS Number:1014R
Sefton Resources Inc
20 October 2003

                     Sefton Resources, Inc. ("the Company")

                Placing of 167,725,000 New Common Shares at 0.2p

The Company announces that it has today placed 167,725,000 New Common Shares at
0.2p per share to raise #335,450 before expenses. The New Common Shares will
rank parri passu with the existing Common Shares.

The Directors of the Company have subscribed for New Common Shares in the
Placing as follows:

Name                           New Common Shares

K. F. Arleth                   9,000,000
A. R. H. Thomas                7,800,000
J. J. Ellerton                 7,500,000
N. M. Thachuk                  1,100,000

The Directors' interest in the share capital of the Company, following the
Placing, will now be as follows:

                              
                                            

   Name               Common      Percentage of the issued share capital of
                      Shares                     the Company

K. F. Arleth          30,166,667                   4.87

A. R. H. Thomas       28,083,334                   4.53

J. J. Ellerton        57,952,900                   9.36

N. M. Thachuk         1,100,000                    0.18


Application has been made for the New Common Shares to be admitted to trading on
the AIM market of the London Stock Exchange and dealings in the New Common
Shares are expected to commence on 24 October 2003.

For further information contact:

Jim Ellerton      +1 303 / 542-1922




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSFEWFMSSDSEDS

1 Year Serina Therapeutics Chart

1 Year Serina Therapeutics Chart

1 Month Serina Therapeutics Chart

1 Month Serina Therapeutics Chart

Your Recent History

Delayed Upgrade Clock